Professional Documents
Culture Documents
morbidity associated
with snakebite
envenomation in
Satara
District action plan
Contents
Background 6
Challenges 6
Need for an action plan. 7
One Health for snakebite management 8
Vision. 8
Scope 8
Goal. 8
Objectives. 8
Objective 1 9
Strategy 1.1: Strengthening promotive, preventive, and rst aid services at health and 9
wellness centers
Strategy 1.2: Awareness generation on snakebite prevention and effective rst aid through 9
community engagement
Strategy 1.3: Multisectoral engagement. 10
Strategy 1.4: Community-based surveillance... 10
Objective 2. 11
Strategy 2.1: Medicine availability for acute management of snakebites.. 11
Strategy 2.2: Equipment and diagnostics. 11
Strategy 2.3: Infrastructure strengthening. 12
Strategy 2.4: Human resource for health 12
Strategy 2.5: Reporting and record-keeping. 13
Strategy 2.6: Facility for transportation... 13
Strategy 2.7: Continuum of care... 14
Objective 3 14
Strategy 3.1: Intersectoral collaboration. 15
Strategy 3.2: Program management unit 16
Objective 4 17
Strategy 4.1: Facility assessment.. 17
Strategy 4.2: Regular monitoring and evaluation. 17
Strategy 4.3: Public notication and community-based surveillance 18
Monitoring progress.. 18
Annexure 1: Snakebite management protocol 20
Annexure 2: Medicine availability for snakebite management 21
Annexure 3: Equipment and diagnostics. 22
Endnotes 23
Background
Snakebite envenoming stands as a pressing global health issue, profoundly impacting the lives
of countless individuals worldwide. The World Health Organization (WHO) approximates an
annual occurrence of approximately 5 million snakebites, leading to up to 2.7 million cases of
envenoming. Reports in the public domain indicate an annual toll of fatalities, ranging from
81,000 to 138,000. This perilous condition also precipitates a substantial number of amputations
of up to 400,000, along with enduring disabilities like blindness, amputation, and post-traumatic
1
stress disorder, primarily owing to the absence of adequate post-treatment care. Click or tap
here to enter text. It is estimated that there are over 1,000,000 snakebites in India alone causing
58,000 deaths annually and signicant disability in almost four times the number. 2Click or tap
here to enter text. However, the National Health Prole 2019 data on snakebites reported
164,031 snakebite cases and 885 deaths in 2018, 3Click or tap here to enter text. which shows a
huge discrepancy in reported data. A signicant portion of snakebite incidents go unreported,
often as a result of victims seeking non-medical remedies or experiencing limited access to
4
proper health care facilitiesClick or tap here to enter text. India's rural population, which is
characterized by high biodiversity and densely populated areas, is particularly vulnerable to
snakebite envenoming. It is often associated with poverty, affecting vulnerable populations such
as agricultural workers, shermen, working children, and families residing in inadequately
constructed housing.
In India, around 90 percent of poisonous snakebites are caused by the “big four” among the
crawlers: common krait, Indian cobra, Russell's viper, and saw-scaled viperClick or tap here to
5
enter text. . Envenoming due to these snakes can lead to severe paralysis, bleeding disorders,
muscle breakdown, kidney failure, and extensive local tissue damage, often resulting in
permanent disability. Tragically, many of these deaths and severe consequences are
preventable through the availability and administration of safe and effective antivenomsClick or
6
tap here to enter text. . Unfortunately, due to a lack of awareness, knowledge, and access to
health care, young people and children in disadvantaged rural areas continue to bear a
disproportionate burden of snakebite envenoming. Additionally, it represents a signicant cause
of maternal morbidity and pregnancy loss, highlighting the urgent need for comprehensive
intervention strategies.
Challenges
Satara is a district situated in India's Western Ghats. Most of its terrain is covered by forests and
hills, making the local population “at risk” for snakebite envenoming. Villages along the Sahyadri
ranges are mostly separated by rivers and hills with poor road connectivity, making access to
health care a big challenge. Even though the population is vulnerable to snakebite
envenomation, most of the cases are not reported as the locals prefer traditional medicines or
die before reaching health care facilities.
At the community level, there is also a lack of knowledge about identifying at-risk areas,
preventive measures to mitigate human-snake interactions, and the availability of treatment at
public health facilities. Also, accredited social health activists (ASHAs) and staff from health and
wellness centers (HWCs) often lack training in community engagement and effective rst aid,
leading to underreporting of cases.
Health care facility staff members are frequently inadequately trained in the latest treatment
protocols, particularly at the primary level. This lack of proper rst aid and primary management
places an increased burden on higher-level facilities. Research has shown that delayed
administration of antivenoms increases the likelihood of fatalities in cases of snakebiteClick or
tap here to enter text.7.
The Indian Council of Medical Research (ICMR) National Task Force for Research on Snakebite
has outlined a roadmap focused on rapid diagnostics, antivenom development, guideline
dissemination, legislative changes, awareness campaigns, and media outreach. The Mission
Steering Group, responsible for strategy development and implementation within the National
Health Mission, has emphasized community awareness and health worker capacity building to
address the issue of snakebites. However, a comprehensive health care system strengthening
approach, with a particular emphasis on timely and effective service delivery at the primary
health care level, is indispensable for snakebite preventionClick or tap here to enter text.9.
As snakebite is a medical emergency. Providing care at the primary health care level, which is in
close proximity to bite incident locations, is paramount for reducing snakebite-related mortality
and morbidity. With the operationalization of Ayushman Bharat health and wellness centers (AB-
HWCs), health care has become more accessible to communities. However, it is crucial to
establish a service delivery framework at each level of health care facilities. To effectively
implement best practices and policies at the grassroots level, it is essential to involve
herpetologists, forest department ofcials, panchayat representatives, village elders, inuential
community members, and school teachers. Emphasizing community engagement throughout
the decision-making and implementation processes calls for decentralization of both authority
and nancial resources, ensuring a more inclusive and effective approachClick or tap here to
enter text.10. Therefore, the action plan will also focus on community engagement to generate
awareness and community-level surveillance for improving health-seeking behavior. Strategies
are being designed for multisectoral engagement based on the One Health approach for
enhancing surveillance and identifying areas of improvement. This district-level plan is designed
to address the mentioned challenges and provide a comprehensive action plan that addresses
the entire ecosystem of snakebite management.
Vision
To make Satara district in the State of Maharashtra free of mortality and morbidity due to
snakebite envenoming.
Scope
This is a district-specic action plan for implementation, planning, and monitoring of strategies to
prevent snakebite-related deaths. This document focuses on district- and facility-level
stakeholders including district and block ofcers, health facility staff, eld-level workers,
community members, and concern ofcers from other sectors.
Goal
To reduce snakebite-related deaths in Satara district by 50 percent by the end of 2026 (The
short-term goal is reducing morality by 20 percent by the end of 2024.).
Objectives
Major local challenges can be effectively addressed through the following four measures:
Ÿ Prevent snakebites and improve rst aid management through effective community
engagement
Ÿ Provide access to quality life-saving treatment services by ensuring continuum of care at all
levels of health facilities
Ÿ Strengthen institutional capacity for effective leadership and management of the program to
ensure progress
Objective 1
Prevent snakebites and improve rst aid management through
effective community engagement
Snakebite emergencies are often linked to environmental conditions, lack of access to proper
education, and occupations such as agriculture, shery, forest dwellers, children engaged in
labor work. The majority of the population in Satara district resides in the hills of the Sahyadri
ranges, living in poorly constructed housing in isolation due to poor road connectivity to city.
Lack of transportation options due to unique geographical conditions render them particularly
vulnerable to snakebite-related emergencies.
Also, as most of the young population migrated to metro cities for livelihood opportunities, the
elderly population often resorts to traditional healers as their preferred health care providers.
Lack of awareness on prevention of snakebites and of the availability of a public health care
system also affects decision making, causing high levels of unreported snakebite-related
morbidity and mortality cases. These emergencies can be prevented by spreading awareness
on prevention, medicine availability, and proper rst aid measures at the community and HWC
levels.
Ÿ Training of CHOs on effective rst aid, primary clinical management, and referral of cases.
Ÿ Availability of the required material for rst aid and emergency drugs at HWCs. Provision of
cots, bed nets, footwears, and torches for vulnerable groups.
Ÿ Community training on prevention, effective rst aid, availability of treatment options and
proper methods of transportation. This training should be based on updated guidelines and
tailored based on the local context.
Ÿ Display IEC material at HWCs and PHCs on rst aid after snakebite and prevention of
snakebites in panchayats and other public places.
Ÿ Involvement of “local champions”, political leaders, and faith healers who have high inuence
on society to address the community on seeking better health care.
Ÿ Gram sabha members should ensure availability of basic tools for rst aid such as wooden
splints and crape bandage at every gram panchayat.
Ÿ The agriculture and forest departments can help identify practices leading to human snake
interactions and participate in public awareness campaigns.
ASHAs and MPWs will be responsible to notify the HWC of potential snakebite deaths.
Review of potential snakebite deaths during Jan Arogya Samiti meetings to identify causes and
plan appropriate actions.
Priority actions
Ÿ Development and distribution of IEC material, toolkits, posters on awareness
generation for the prevention of snakebite emergencies.
Ÿ Capacity building of ASHAs and ASHA supervisors on prevention and community
mobilization for snakebite prevention
Ÿ Sensitization of community and Jan Arogya Samiti members.
Objective 2
Access to quality life-saving treatment services by ensuring
continuum of care at all levels of health facilities
Health system strengthening through a comprehensive primary care preparedness across all
domains is crucial to prevent snakebite-related casualties in India. Structural capacity at all
levels of health facilities needs to be developed in terms of medicine, equipment, infrastructure,
human resources, and health management information system. Strategies need to be
developed in a holistic way after considering all these domains.
Ÿ Ensure correct indenting and proper storage at the facility level to avoid wastage of drugs.
Ÿ Availability of ASV, emergency drugs, and other required medicines at highly remote HWCs.
Dedicated snakebite management kits are to be prepared for each facility (see Annexures)
Ÿ The district store is to ensure availability of quality ASVs and uninterrupted supply from the
state.
Ÿ Forecasting the need for ASVs is crucial. Annual requirement is to be calculated based on
the past year's use at PHCs and ensuring adequate quantity plus 10 percent extra.
Ÿ Availability of ASVs and emergency drugs should be a part of regular weekly and monthly
reviews at the block and district levels.
Ÿ Cases in which ASV was administered in time but not found to be effective should be
reported.
Ÿ Availability of proper drug storage facility, especially at the AB HWC SC where ASV is
provided.
Strategy 2.3: infrastructure strengthening
Ÿ Assessment of the existing facilities will be done for following elements:
Ÿ Residential facility inside the campus for the medical ofcer and staff nurse
Ÿ DH: At least 3 medical ofcers, 4 staff nurses, and 2 attendants round the clock for the
emergency department; medical ofcers and staff nurses as per ICU beds; and 1 full-time
specialist physician, lab technician, and pharmacy ofcer
Ÿ SDH / CHC: 2 medical ofcers 2 staff nurses, and 2 attendants for the emergency
department and 1 physician, lab technician, and pharmacy ofcer
Ÿ PHC: At least 1 medical ofcer and 1 staff nurse, lab technician, and pharmacy ofcer
Capacity building of health facility staff at all levels for clinical management of snakebite cases
and management of complications for CHC and DH as per latest guidelines and protocols.
Technical support can be provided by the existing development partners—presently, PATH.
Community HWC-HSC HWC-PHC CHC DH
Provide rst aid to Look for obvious - ABC (Airway, breathing, -ABC - ABC
patient and follow Right evidence of a bite, circulation) - Administer ASV - Administer ASV
approach: bleeding, swelling of the - Secure IV/IO line in immediately if signs of immediately if signs of
R: Reassure the patient bitten area: HWC-PHC envenomation observed envenomation observed
I: Immobilize the limb - Reassure the patient and use normal saline to - Follow treatment - Follow treatment
using splint - Immobilize the keep IV access open. protocol (Annexure 1) protocol (Annexure 1)
G H: Get to the Hospital limb/body part with bite - IV uids, if patient is in - Investigations for PT - Investigations for PT
immediately where ASV - Remove shoes, rings, shock. INR, LFT, RFT, urine INR, LFT, RFT, Urine
is available watches, jewelry, and - Draw 20 ml blood for examination, urine examination, urine
T: Tell about the tight clothing from the Whole Blood Clotting output to be observed output to be observed
symptoms developed bitten area Time and send results to - Ventilation support if - Ventilation support if
- Leave the blisters higher centre (if patient required required
undisturbed has already left the - Discharge only if kidney - Transfer to nephrology /
- Identify signs of HWC-PHC) function is normal and dialysis if abnormal urine
envenoming - Evaluate and monitor patient is stable output observed
- Conduct WBCT while for sign of poisoning, - Follow up for post- - Discharge only if kidney
refrring patient to higher toxicity and early discharge complications function is normal and
facility and communicate administration of - Availability of blood patient is stable
the results antivenom products, Blood storage - Follow up for post-
- Primary treatment can unit is desirable discharge complications
be initiated by a CHO in - Availability of blood
remote HWCs bank
- Arrange transport of the
patient to nearest facility
with ASV by ambulance
- Follow up of discharged
cases
Ÿ All facilities should ensure timely and correct reports on both portals
Ÿ The HWC will include record-keeping for cases of morbidity and deaths not reported to the
hospital. Information to be collected from community, discussed during Jan Arogya Samiti
meetings, and reported to district
Ÿ Operationalize fully equipped boat ambulances along with trained medical/paramedical staff
for areas only or better accessible by water ways
Ÿ Training of ambulance staff on basic life support and the clinical recognition of envenoming
and rapid effective response to life-threatening emergencies such as shock, major bleeding,
airway obstruction, respiratory paralysis, and anaphylactic reactions while in-transit to referral
facility.
Strategy 2.7: Continuum of care
Development and distribution of appropriate IEC, toolkits, posters based on standard protocols
across districts
Develop district-specic standard referral protocols based on availability of services, which will
include early signs of complications, list of standard transfer criteria, steps to prevent clinical
worsening during transit (such as importance of maintaining hemodynamic and respiratory
stability before and during transfer).
Provision of cue cards to facilities having information of higher referral centers having ASVs and
essential critical care services for snakebite management. Cases should be referred to only
such facilities to avoid delay in treatment. Ensure communication between facilities.
All facilities will maintain record for referral cases and ensure follow up especially at HWC level
for discharged cases so that post treatment morbidities can be avoided.
Provision of referral slip specically for snakebite cases mentioning clinical observations,
investigations and specic treatment provided for effective communication to higher referral
center.
List of nearby health centers with availability of snakebite management services should be
provided to communities / Jan Arogya Samitis in at risk areas.
Establishing a team of snakebite mentors at the district level who can be available to answer
queries from the eld about snakebite management.
Priority actions
Ÿ Distribution of standard treatment protocols at all facilities as per latest guidelines
and capacity building of facility staff on treatment guidelines.
Ÿ Develop standard referral protocols as per service availability at higher referral
facilities.
Ÿ Development of standard protocols for ambulance staff to manage complications
in transit.
Ÿ Ensuring regular reporting and record-keeping for identication, management,
and referral of cases.
Objective 3
Strengthen district capacity for effective leadership and
management of the program to ensure progress
A stronger leadership and effective program monitoring specic to snakebite envenoming is
required to boost activities and improve delay in treatments, unavailability of ASVs, loss-to-
follow-up cases, underreporting and ultimately increased casualty. A continuous structure
process improvement model will be adopted to plan necessary actions in a timely manner.
Also, as mentioned earlier, multisectoral engagement (One Health approach) will be a crucial
part of district leadership to achieve our vision. Having sectors such as agriculture, environment,
veterinary, education, forest on board can contribute to planning and monitoring actions in a
holistic manner.
Health
Organize training programs for
health care for prevention and Agriculture
effective management of snakebites Identify and address issues related
Education and administration of ASVs to snake habitats in areas where
Introduction of snakebite awareness Ensure a constant supply of ASVs agriculture practices contribute to
and rst aid training into the with proper storage and adequate snake-human conicts. Changes in
educational curriculum distribution to health care facilities land use or farming practices to can
Educate students and teachers Prepared facilities with essential be recommended in at-risk farming
about snakebite prevention, rst infrastructure and equipment for such as paddy.
aid, and appropriate responses snakebite management Strategies to be developed to
Collaborate with health care Community engagement through mitigate conicts between
facilities (HWCs) to conduct public Jan Aarogya Samitis at the HWC agriculture activities and snakes,
awareness campaigns about level for snakebite prevention ensuring the safety of both farmers
snakebite prevention, safe and local snake populations.
environmental practices, and the Monitor incidences among farmers
importance of timely medical and provide nancial assistance to
intervention dependents of snakebite victims
Forest Veterinary
Maintain ecosystems in forested The veterinary department will
areas to reduce snake-human collaborate on animal husbandry
conicts through habitat practices aimed at minimizing
conservation, addressing factors snake-human conicts. This
that attract snakes to human Snakebite includes ensuring the safety of
habitats, and preserving natural prevention and livestock and pets and advocating
snake habitats. for the humane handling of snakes
management
Educate Forest personnel to rescue to prevent unnecessary harm to
and relocate venomous snakes both humans and snakes.
found in or near human settlements. Communicate incidents of
Data Collection on forest snake snakebites among animals reported
populations, species, their to understand at risk areas and
behaviors, and distribution. And practices
share it with other departments for
understanding and mitigating
snakebite risks.
Participate in snakebite awareness
programs, helping to educate local
communities on snakebite
prevention and rst aid and
conservation of endangered
species
Planning and coordination: The committee will be responsible for developing comprehensive
plans for snakebite envenoming prevention, treatment, and awareness. It will coordinate the
efforts of various departments and organizations involved in these initiatives within the district.
This coordination will ensure a holistic approach to tackle the issue effectively.
Progress review: The committee should have a bimonthly or need-based meetings to review
progress of planned activities and revise actions based on enablers and challenges.
Casualty/death review: The committee will analyze data on snakebite casualties within the
district to identify patterns, locations with a higher incidence of snakebites, and emerging trends.
This data-driven approach is crucial for targeting interventions where they are most needed.
Action planning: Based on the ndings from casualty reviews, the committee will develop and
implement specic action plans. Based on the latest ndings, these plans may cover a range of
measures, including enhancing rst aid responses, ensuring adequate medical facilities,
managing the ecosystem, and raising public awareness about snakebite prevention.
Resource allocation: To ensure readiness for snakebite emergencies, the committee will make
recommendations for the allocation of resources with a particular focus on availability of ASV
and other necessary medical supplies, availability of trained HR, and logistics for public
campaigns.
Financial assistance to victims: The committee will verify that nancial aid is provided to the
victims. Presently, the schemes exclusively address accidents involving farmers in accordance
with state policy. A review should be conducted to assess any potential amendments in the
future.
Figure 3: Continuous structure and process improvement model for snakebite prevention (district approach).
Priority actions
Ÿ Form of district core committee and conduct orientation meeting to dene vision,
goals, and primary responsibilities.
Ÿ Sensitize PMU on individual responsibilities and implementation of priority action
items dened by the steering committee.
Objective 4
Establish effective surveillance and monitoring mechanisms for
snakebite-related emergencies
One of the primary challenges faced at the district level in preventing and managing snakebite
envenoming is the scarcity of high-quality epidemiological surveillance data. Access to timely
and dependable data is crucial for making informed decisions and planning effective strategies.
Such data is an essential component of a robust primary health care system and vital for
addressing snakebite-related emergencies.
Ÿ Existing facility assessment tools will be used after integrating the mentioned indicators.
Ÿ District and block managers will ensure that all snakebite incidents are discussed during
review meetings.
Ÿ Regular review during Jan Arogya Samitis can help identify risk areas and factors that will be
notied to the district PMU by the CHO.
Priority actions
Ÿ Conduct gap assessment for facilities across all domains and identify gaps for
developing plan for gap lling by district authorities.
Ÿ Identify gaps in reporting and communicate to facilities for validation of data.
Ensure regular reporting on HMIS and IHIP.
Ÿ Establish mechanism for reporting of adverse drug reactions during treatment.
Ÿ Sensitize Jan Arogya Samiti members on the importance of community-based
surveillance and create WhatsApp groups for immediate notication of incidents.
Same should be communicated to the district by CHOs.
Monitoring progress
To ensure the effectiveness of the action plan, a systematic monitoring process should be set in
place. This involves baseline, midline, and endline assessments of health care facilities to
gauge the impact of the designed plan. Regular progress checks are vital to ensure the correct
implementation of strategies. The following indicators will be monitored through existing
reporting channels and regular support visits by district and block teams:
Facility-level indicators
Ÿ The total number of facility staff trained in the latest snakebite management protocols
Ÿ The number of ASHAs trained in preventive measures, rst aid, and surveillance
Ÿ The number of community training sessions conducted in the catchment area for AB-HWCs
Ÿ The total number of snakebite cases reported to the facility
Ÿ The total number of snakebite cases provided with primary aid at the facility
Ÿ The total number of snakebite cases managed at the facility
Ÿ The total number of snakebite cases referred to higher-level facilities
Ÿ The total number of deaths attributed to snakebites
Ÿ The number of instances of stock-outs of ASV
Ÿ The number of instances of stock-outs of emergency drugs
Ÿ The number of Jan Arogya Samiti meetings conducted (check for minutes of meeting)
District-level indicators
Ÿ The number of district steering committee meetings conducted
Ÿ The number of PMU meetings conducted.
Ÿ The number of district- or block-level meetings conducted where snakebite incidents were
discussed.
This monitoring system ensures that the action plan progresses effectively and that the
necessary adjustments are made to achieve our goal of reducing snakebite-related morbidity
and mortality in Satara district.
Annexure 1: Snakebite management protocol
Annexure 2: Medicine availability for snakebite
management
HWC-SC
Ÿ Adrenaline inj 1mg/ml (desired for remote
HSC)
Ÿ Anti-snake venom (desired for remote HSC)
Ÿ Normal saline
HWC-PHC
Ÿ Inj Adrenaline
Ÿ Inj Atropine
Ÿ Inj Neostigmine
Ÿ Inj Tetanus toxoide
Ÿ Anti-snake venoms
Ÿ Normal saline
RH / SDH
Ÿ Inj Adrenaline
Ÿ Inj Atropine
Ÿ Inj Neostigmine
Ÿ Inj Tetanus toxoide
Ÿ Anti-snake venoms
Ÿ Chlorpheniramine / cetrizine
Ÿ Analgesics
Ÿ Epinephrine
Ÿ Antibiotics
Ÿ Normal saline
Annexure 3: Equipment and diagnostics
Equipment Diagnostics
PHC IV sets, pulse oximeter, Ambu bag WBCT, RFT (D), Urine (D), LFT(D)
(adult and neonatal), wooden splints,
crape bandage, BP apparatus,
laryngoscope, ET tube
SDH IV sets, pulse oximeter, Ambu bag PT INR, RFT, LFT, Urine,
(adult and neonatal), wooden splints, blood grouping, CBC, imaging
crape bandage, BP apparatus,
laryngoscope, ET tube, mobile
ventilators, blood bank, oxygen supply,
critical care units
DH IV sets, pulse oximeter, Ambu bag (adult PT INR, RFT, LFT, Urine,
and neonatal), wooden splints, crape blood grouping, CBC, imaging
bandage, BP apparatus, laryngoscope,
ET tube, ventilator, dialysis unit, blood
bank, debrillator, oxygen supply,
critical care units
Endnotes
1
Snakebite envenoming [Internet] [cited Nov 17, 2023], https://www.who.int/news-room/fact-
sheets/detail/snakebite-envenoming#cms
2
B. Mohapatra, D.A. Warrell, W. Suraweera, P. Bhatia, N. Dhingra, R.M. Jotkar, et al, “Snakebite
mortality in India: a nationally representative mortality survey,” PLoS Negl Trop Dis [Internet].
2011 Apr [cited Nov 17, 2023]; 5(4):e1018,
https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0001018; W. Suraweera, D.
Warrell, R. Whitaker, G. Menon, R. Rodrigues, S.H. Fu, et al, “Trends in snakebite deaths in
India from 2000 to 2019 in a nationally representative mortality study,” Elife [Internet]. 2020 Jul 1
[cited Nov 17, 2023]; 9:1–37, https://pubmed.ncbi.nlm.nih.gov/32633232/
3
Central Bureau of Health Intelligence, National Health Prole 2019, 14th Issue [Internet]. 2019
[cited Nov 17, 2023], https://cbhidghs.mohfw.gov.in/showle.php?lid=1147
4
J. Chakma, J. Menon, R. Dhaliwal, “White paper on venomous snakebite in India,” Indian J
Med Res [Internet]. 2020 Dec 1 [cited Nov 17, 2023]; 152(6):568–74,
https://pubmed.ncbi.nlm.nih.gov/34145096/
5
Snakebite envenoming India [Internet]. [cited Nov 17, 2023], https://www.who.int/india/health-
topics/snakebite
6
J.M. Gutiérrez, J.J. Calvete, A.G. Habib, R.A. Harrison, D.J. Williams, D.A. Warrell, “Snakebite
envenoming,” Nature Reviews Disease Primers 2017 3:1 [Internet]. 2017 Sep 14 [cited Nov 17,
2023];3(1):1–21, https://www.nature.com/articles/nrdp201763
7
J.M. Gutiérrez, J.J. Calvete, A.G. Habib, R.A. Harrison, D.J. Williams, D.A. Warrell, “Snakebite
envenoming,” Nature Reviews Disease Primers 2017 3:1 [Internet]. 2017 Sep 14 [cited Nov 17,
2023];3(1):1–21, https://www.nature.com/articles/nrdp201763
8
S. Bhaumik, R. Norton, J. Jagnoor, “Structural capacity and continuum of snakebite care in the
primary health care system in India: a cross-sectional assessment,” BMC Primary Care
[Internet]. 2023 Dec 1 [cited Nov 17, 2013]; 24(1):1–11,
https://bmcprimcare.biomedcentral.com/articles/10.1186/s12875-023-02109-2
9
R.K. Gajbhiye, I.K. Chaaithanya, H. Munshi, R.K. Prusty, A. Mahapatra, S.K. Palo, et al.
“National snakebite project on capacity building of health system on prevention and
management of snakebite envenoming including its complications in selected districts of
Maharashtra and Odisha in India: a study protocol,” PLoS One [Internet]. 2023 Feb 1 [cited Nov
17, 2023]; 18(2):e0281809,
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0281809
10
R.K. Gajbhiye, H. Munshi, H.S. Bawaskar, “National programme for prevention and control of
snakebite in India: key challenges and recommendations,” Indian J Med Res [Internet]. 2023
Apr 1 [cited Nov 17, 2023]; 157(4):271, /pmc/articles/PMC10438420/
NOTE
Address:
15th Floor, Dr. Gopal Das Bhawan,
28, Barakhamba Road,
New Delhi - 110001